Innovating Alzheimer’s disease therapeutics: research, treatment, and care
Innovating Alzheimer’s disease therapeutics: research, treatment, and care
0:00
|
0:00

PREVIEW
Description
In this video, Steven Gourlay, the CEO and Managing Director of Act Antigen, provides valuable insights into their clinical-stage company's groundbreaking therapy for Alzheimer's disease and depression.
Gain valuable insights into the exciting advancements in Alzheimer's disease therapeutics and the potential for improved patient outcomes.
Table Of Contents
Actinogen medical innovative approaches
Key challenges and unmet needs in the current landscape of Alzheimer's Disease therapeutics
Promising findings in Actinogen Medical's small molecule therapeutics for Alzheimer's Disease
Primary goals and milestones of Actinogen Medical
The future of Alzheimer's
0
Your cart